Center Eligibility
A transplant center is eligible for an audit after performing a minimum of 20 eligible transplants (any combination of related or unrelated allogeneic and autologous). From the completed transplants, 16 eligible transplant events are selected for audit. Once a recipient is determined to be eligible for audit, forms submitted without errors in FormsNet will be audited. US-based centers who have not performed 20 transplants will be deferred from the audit process until they have reached their 20th transplant.

Currently, the CIBMTR audits non-US-based centers whose medical records are primarily documented in English and whose staff speaks English. In addition to the above listed eligibility criteria, we will also identify whether the non-US center has utilized a donor or product from the US. If not, we may not conduct an audit at the center even if they meet all other eligibility criteria.

Recipient Eligibility
For a recipient to be eligible for audit, one of the following form combinations must be submitted error-free (in CMP status) to FormsNet:

  • Pre-Transplant Essential Data (TED) (2400) Form, Disease Classification (2402) Form, and 100 Day Post-TED (2450) Form
  • Pre-Transplant Essential Data (TED) (2400) Form, Disease Classification (2402) Form, Recipient Baseline (2000) Form, and 100 Day Post-Infusion Follow-up (2100) Form

Form Eligibility
Forms that are in complete status at the time recipients are randomly selected for audit (approximately six to eight weeks prior to the audit date) are eligible. Once a recipient is selected for audit, all forms to be audit will be locked in FormsNet and no changes will be allowed to be made by the center. The following forms may be audited:

  • Pre- and Post-Transplant Essential Data (Forms 2400, 2402 and 2450)
  • Baseline Data (Form 2000)
  • Post-Infusion Follow-up (Form 2100)
  • Six Month to Two Year Follow-Up (Form 2200 – retired)
  • Greater than Two Year Follow-Up (Form 2300 — retired)
  • Death Data (Form 2900)
  • All corresponding disease, infectious disease markers, HLA typing, infection, and infusion inserts
Last modified: Jan 16, 2024

Feedback

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.

Post your comment on this topic.

Post Comment